B. Bellier

发表

Intranasal DNA vaccination induces potent mucosal and systemic immune responses and cross-protective immunity against influenza viruses.

B. Lambrecht, D. Klatzmann, Lea Torrieri-Dramard, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Tumor emergence is sensed by self-specific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice.

D. Klatzmann, K. Podsypanina, B. Bellier, 2009, The Journal of clinical investigation.

Immunodepression and Immunosuppression During Aging

D. Klatzmann, B. Bellier, Hang-Phuong Pham, 2012 .

Efficient oral vaccination by bioengineering virus-like particles with protozoan surface proteins

D. Klatzmann, T. Sparwasser, B. Bellier, 2019, Nature Communications.

Systems biology in vaccine design

D. Klatzmann, B. Bellier, A. Six, 2012, Microbial biotechnology.

7 Immunodepression and Immunosuppression During Aging

D. Klatzmann, B. Bellier, Hang-Phuong Pham, 2012 .

Peripheral ChE Inhibition Modulates Brain Monoamines Levels and c-fos Oncogene in Mice Subjected to a Stress Situation

B. Bellier, L. Taysse, D. Christin, 2005, Neurochemical Research.

Quantifying Lymphocyte Division, Methods

J. Hasenauer, D. Klatzmann, B. Bellier, 2013 .

Recombinant retrovirus‐like particle forming DNA vaccines in prime‐boost immunization and their use for hepatitis C virus vaccine development

F. Cosset, S. Kochanek, D. Klatzmann, 2009, The journal of gene medicine.

Replication-competent vectors and empty virus-like particles: new retroviral vector designs for cancer gene therapy or vaccines.

D. Klatzmann, B. Bellier, N. Kasahara, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Preservation of graft-versus-infection effects after suicide gene therapy for prevention of graft-versus-host disease.

D. Klatzmann, L. Lejeune, B. Bellier, 2000, Human gene therapy.

Transient control of a virus-induced immunopathology by genetic immunosuppression

D. Klatzmann, B. Bellier, M. Saron, 2000, Gene Therapy.

Turning immunological memory into amnesia by depletion of dividing T cells

D. Klatzmann, B. Bellier, M. Saron, 2003, Proceedings of the National Academy of Sciences of the United States of America.

High diversity of the immune repertoire in humanized NOD.SCID.γc−/− mice

D. Klatzmann, C. Caux, B. Bellier, 2009, European journal of immunology.

Sustained stimulation and expansion of Tregs by IL2 control autoimmunity without impairing immune responses to infection, vaccination and cancer.

B. Lambrecht, D. Klatzmann, V. Jiménez, 2014, Clinical immunology.

tolerogenic environment for tumors in mice

D. Klatzmann, K. Podsypanina, B. Bellier, 2009 .

The regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammation

D. Klatzmann, P. Moingeon, B. Bellier, 2016, Mucosal Immunology.

Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice.

D. Klatzmann, B. Bellier, B. Combadière, 2013, Vaccine.

Low-Dose IL-2 Induces Regulatory T Cell–Mediated Control of Experimental Food Allergy

D. Klatzmann, B. Bellier, F. Pitoiset, 2016, The Journal of Immunology.

Prolonged allograft survival through conditional and specific ablation of alloreactive T cells expressing a suicide gene.

D. Klatzmann, B. Bellier, D. Glotz, 2000, Transplantation.

Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.

D. Klatzmann, S. Pol, L. Musset, 2017, Gastroenterology.

Tetraspanins displayed in retrovirus-derived virus-like particles and their immunogenicity.

D. Klatzmann, P. Alves, M. Carrondo, 2016, Vaccine.

Efficient oral vaccination by bioengineering virus-like particles with protozoan surface proteins

D. Klatzmann, T. Sparwasser, B. Bellier, 2019, Nature Communications.

DNA vaccines expressing retrovirus-like particles are efficient immunogens to induce neutralizing antibodies.

P. Desprès, D. Klatzmann, F. Tangy, 2009, Vaccine.

A novel strategy for molecular signature discovery based on independent component analysis

Hang Phuong Pham, Nicolas Dérian, Wahiba Chaara, 2014, Int. J. Data Min. Bioinform..

Enveloped virus-like particle platforms: vaccines of the future?

B. Bellier, F. Pitoiset, T. Vazquez, 2015, Expert review of vaccines.

TGF-β and VEGF cooperatively control the immunotolerant tumor environment and the efficacy of cancer immunotherapies.

D. Klatzmann, B. Bellier, Djamel Nehar-Belaid, 2016, JCI insight.

Virus-like particle-based vaccines against hepatitis C virus infection

D. Klatzmann, B. Bellier, 2013, Expert review of vaccines.

T-Cell suicide gene therapy for organ transplantation: induction of long-lasting tolerance to allogeneic heart without generalized immunosuppression.

D. Klatzmann, B. Bellier, D. Glotz, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

A Prime-Boost Strategy Using Virus-Like Particles Pseudotyped for HCV Proteins Triggers Broadly Neutralizing Antibodies in Macaques

P. Mangeot, D. Lavillette, F. Cosset, 2011, Science Translational Medicine.

Human and Mouse CD8+CD25+FOXP3+ Regulatory T Cells at Steady State and during Interleukin-2 Therapy

D. Klatzmann, B. Bellier, M. Rosenzwajg, 2015, Front. Immunol..

Efficacy of DNA vaccines forming e7 recombinant retroviral virus-like particles for the treatment of human papillomavirus-induced cancers.

E. Tartour, D. Klatzmann, B. Bellier, 2013, Human gene therapy.

A Thermostable Oral SARS-CoV-2 Vaccine Induces Mucosal and Protective Immunity

D. Klatzmann, B. Bellier, H. Luján, 2021, bioRxiv.

Skin decontamination of mustards and organophosphates: comparative efficiency of RSDL and Fuller's earth in domestic swine

B. Bellier, L. Taysse, S. Delamanche, 2007, Human & experimental toxicology.

Different immunogenicity but similar antitumor efficacy of two DNA vaccines coding for an antigen secreted in different membrane vesicle-associated forms

C. Théry, O. Lantz, Lea Torrieri-Dramard, 2014, Journal of extracellular vesicles.

DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant.

F. Cosset, D. Klatzmann, B. Bellier, 2006, Vaccine.

Regulatory T‐cell development and function are impaired in mice lacking membrane expression of full length intercellular adhesion molecule‐1

B. Lambrecht, D. Klatzmann, B. Bellier, 2015, Immunology.

Intra-cheek immunization as a novel vaccination route for therapeutic vaccines of head and neck squamous cell carcinomas using plasmo virus-like particles

E. Tartour, B. Bellier, A. Carpentier, 2016, Oncoimmunology.

Protection against soman-induced neuropathology and respiratory failure: a comparison of the efficacy of diazepam and avizafone in guinea pig.

B. Bellier, L. Taysse, S. Delamanche, 2006, Toxicology.

Identification of a Dominant Epitope in the Hemagglutinin of an Asian Highly Pathogenic Avian Influenza H5N1 Clade 1 Virus by Selection of Escape Mutants

B. Lambrecht, D. Klatzmann, Lea Torrieri-Dramard, 2010, Avian diseases.

Retrovirus-Based Virus-Like Particle Immunogenicity and Its Modulation by Toll-Like Receptor Activation

D. Klatzmann, B. Bellier, Djamel Nehar-Belaid, 2017, Journal of Virology.

Early Transcriptome Signatures from Immunized Mouse Dendritic Cells Predict Late Vaccine-Induced T-Cell Responses

Nicolas Dérian, Bertrand Bellier, Hang-Phuong Pham, 2016, PLoS Comput. Biol..

Retrovirus-Derived Virus-Like Particles

D. Klatzmann, B. Bellier, C. Dalba, 2015 .

Epigenome-wide association study of rheumatoid arthritis identifies differentially methylated loci in B cells

D. Absher, D. Klatzmann, W. Farrell, 2017, Human molecular genetics.

High diversity of the immune repertoire in humanized NOD.SCID.γc−/− mice

D. Klatzmann, C. Caux, B. Bellier, 2009, European journal of immunology.

Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.

D. Klatzmann, S. Pol, L. Musset, 2017, Gastroenterology.

Early Transcriptome Signatures from Immunized Mouse Dendritic Cells Predict Late Vaccine-Induced T-Cell Responses

D. Klatzmann, B. Bellier, A. Six, 2016, PLoS Comput. Biol..

Induction of Acute Lung Injury after Intranasal Administration of Toxin Botulinum A Complex

J. Calvet, B. Bellier, L. Taysse, 2005, Toxicologic pathology.

Retrovirus-Based Virus-Like Particle Immunogenicity and Its Modulation by Toll-Like Receptor Activation

D. Klatzmann, B. Bellier, Djamel Nehar-Belaid, 2017, Journal of Virology.

Particulate antigens administrated by intranasal and intravaginal routes in a prime-boost strategy improve HIV-specific TFH generation, high-quality antibodies and long-lasting mucosal immunity.

D. Klatzmann, B. Bellier, F. Pitoiset, 2023, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.